Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
MJ Arranz, C Gallego, J Salazar & B Arias. (2016) Pharmacogenetic studies of drug response in schizophrenia. Expert Review of Precision Medicine and Drug Development 1:1, pages 79-91.
Read now
Read now
Maria J Arranz & Janet C Munro. (2011) Toward understanding genetic risk for differential antipsychotic response in individuals with schizophrenia. Expert Review of Clinical Pharmacology 4:3, pages 389-405.
Read now
Read now
Jian-Ping Zhang & Anil K Malhotra. (2011) Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction. Expert Opinion on Drug Metabolism & Toxicology 7:1, pages 9-37.
Read now
Read now
Pallav Bhatnagar, Randeep Guleria & Ritushree Kukreti. (2006) Pharmacogenomics of β2-Agonist: Key Focus on Signaling Pathways. Pharmacogenomics 7:6, pages 919-933.
Read now
Read now
Articles from other publishers (34)
Mujeeb U. Shad. (2023) Pharmacogenomic screening for agranulocytosis and efficacy with clozapine. Journal of Translational Genetics and Genomics 7:3, pages 141-65.
Crossref
Crossref
Thian-Sze Wong, Guangzhi Li, Shiliang Li, Wei Gao, Geng Chen, Shiyi Gan, Manzhan Zhang, Honglin Li, Song Wu & Yang Du. (2023) G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Yuxin Teng, Amrit Sandhu, Edith J. Liemburg, Elnaz Naderi & Behrooz Z. Alizadeh. (2023) The Progress and Pitfalls of Pharmacogenetics-Based Precision Medicine in Schizophrenia Spectrum Disorders: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine 13:3, pages 471.
Crossref
Crossref
Md. Mominur Rahman, Md. Rezaul Islam, Sadia Afsana Mim, Nasrin Sultana, Dinesh Kumar Chellappan, Kamal Dua, Mohammad Amjad Kamal, Rohit Sharma & Talha Bin Emran. (2022) Insights into the Promising Prospect of G Protein and GPCR-Mediated Signaling in Neuropathophysiology and Its Therapeutic Regulation. Oxidative Medicine and Cellular Longevity 2022, pages 1-22.
Crossref
Crossref
Andrea de Bartolomeis, Licia Vellucci, Annarita Barone, Mirko Manchia, Vincenzo De Luca, Felice Iasevoli & Christoph U. Correll. (2022) Clozapine’s multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia. Pharmacology & Therapeutics 236, pages 108236.
Crossref
Crossref
Mujeeb U. Shad. (2021) Genetic Testing for Antipsychotic Pharmacotherapy: Bench to Bedside. Behavioral Sciences 11:7, pages 97.
Crossref
Crossref
V.V. Kravtsov, I.A. Filippov, E.E. Vaiman, N.A. Shnayder & R.F. Nasyrova. (2020) Pharmacogenetic aspects of the dopaminergic system in clozapine pharmacodynamics. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 120:7, pages 134.
Crossref
Crossref
Chao Luo, Junyan Liu, Xu Wang, Xiaoyuan Mao, Honghao Zhou & Zhaoqian Liu. (2019) Pharmacogenetic Correlates of Antipsychotic-Induced Weight Gain in the Chinese Population. Neuroscience Bulletin 35:3, pages 561-580.
Crossref
Crossref
Antonio Rampino, Aleksandra Marakhovskaia, Tiago Soares-Silva, Silvia Torretta, Federica Veneziani & Jean Martin Beaulieu. (2019) Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects. Frontiers in Psychiatry 9.
Crossref
Crossref
Eduard Maron, Chen-Chia Lan & David Nutt. 2019. Treatment Resistance in Psychiatry. Treatment Resistance in Psychiatry
33
63
.
Massimo Carlo Mauri, Silvia Paletta, Chiara Di Pace, Alessandra Reggiori, Giovanna Cirnigliaro, Isabel Valli & Alfredo Carlo Altamura. (2018) Clinical Pharmacokinetics of Atypical Antipsychotics: An Update. Clinical Pharmacokinetics 57:12, pages 1493-1528.
Crossref
Crossref
Shusuke Numata, Hidehiro Umehara, Tetsuro Ohmori & Ryota Hashimoto. (2018) Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis. Frontiers in Pharmacology 9.
Crossref
Crossref
Ruta Samanaite, Amy Gillespie, Kyra-Verena Sendt, Grant McQueen, James H. MacCabe & Alice Egerton. (2018) Biological Predictors of Clozapine Response: A Systematic Review. Frontiers in Psychiatry 9.
Crossref
Crossref
Florence Gressier, Stefano Porcelli, Raffaella Calati & Alessandro Serretti. (2016) Pharmacogenetics of clozapine response and induced weight gain: A comprehensive review and meta-analysis. European Neuropsychopharmacology 26:2, pages 163-185.
Crossref
Crossref
Eva J Brandl, James L Kennedy & Daniel J Müller. (2014) Pharmacogenetics of Antipsychotics. The Canadian Journal of Psychiatry 59:2, pages 76-88.
Crossref
Crossref
Fabiana Barzotti Kohlrausch. (2013) Pharmacogenetics in schizophrenia: a review of clozapine studies. Revista Brasileira de Psiquiatria 35:3, pages 305-317.
Crossref
Crossref
A. P. Rajkumar, B. Poonkuzhali, A. Kuruvilla, A. Srivastava, M. Jacob & K. S. Jacob. (2012) Outcome definitions and clinical predictors influence pharmacogenetic associations between HTR3A gene polymorphisms and response to clozapine in patients with schizophrenia. Psychopharmacology 224:3, pages 441-449.
Crossref
Crossref
Rudi Hwang, Arun K. Tiwari, Clement C. Zai, Daniel Felsky, Eli Remington, Tessa Wallace, Ryan P. Tong, Renan P. Souza, Gabriel Oh, Steven G. Potkin, Jeffrey A. Lieberman, Herbert Y. Meltzer & James L. Kennedy. (2012) Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: Replication and exploration. Progress in Neuro-Psychopharmacology and Biological Psychiatry 37:1, pages 62-75.
Crossref
Crossref
David A Mrazek. (2011) Pharmacogenomic testing to guide treatment using antipsychotic medications. Clinical Investigation 1:11, pages 1513-1521.
Crossref
Crossref
Maria J. Arranz, Margarita Rivera & Janet C. Munro. (2011) Pharmacogenetics of Response to Antipsychotics in Patients with Schizophrenia. CNS Drugs 25:11, pages 933-969.
Crossref
Crossref
Ramón Cacabelos, Ryota Hashimoto & Masatoshi Takeda. (2011) Pharmacogenomics of antipsychotics efficacy for schizophrenia. Psychiatry and Clinical Neurosciences 65:1, pages 3-19.
Crossref
Crossref
Peter P. Zandi & Jennifer T. Judy. (2010) The Promise and Reality of Pharmacogenetics in Psychiatry. Clinics in Laboratory Medicine 30:4, pages 931-974.
Crossref
Crossref
James M. Stone, Marie Raffin, Paul Morrison & Philip K. McGuire. (2009) Review: The biological basis of antipsychotic response in schizophrenia. Journal of Psychopharmacology 24:7, pages 953-964.
Crossref
Crossref
Olivier Blanc, Georges Brousse, Alexandre Meary, Marion Leboyer & Pierre‐Michel Llorca. (2010) Pharmacogenetic of response efficacy to antipsychotics in schizophrenia: pharmacodynamic aspects. Review and implications for clinical research. Fundamental & Clinical Pharmacology 24:2, pages 139-160.
Crossref
Crossref
Peter P. Zandi & Jennifer T. Judy. (2010) The Promise and Reality of Pharmacogenetics in Psychiatry. Psychiatric Clinics of North America 33:1, pages 181-224.
Crossref
Crossref
Ramón Cacabelos. 2009. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes
3
63
.
M. J. Arranz & S. Kapur. (2008) Pharmacogenetics in Psychiatry: Are We Ready for Widespread Clinical Use?. Schizophrenia Bulletin 34:6, pages 1130-1144.
Crossref
Crossref
V. Moulier & D. Januel. (2007) Approche pharmacogénétique de la réponse aux antipsychotiques chez les schizophrènes. L'Encéphale 33:6, pages 954-964.
Crossref
Crossref
M J Arranz & J de Leon. (2007) Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research. Molecular Psychiatry 12:8, pages 707-747.
Crossref
Crossref
Susan G. Leckband, Jeffrey R. Bishop & Vicki L. Ellingrod. (2016) Pharmacogenomics in Psychiatry. Journal of Pharmacy Practice 20:3, pages 252-264.
Crossref
Crossref
Lisa A. Catapano & Husseini K. Manji. (2007) G protein-coupled receptors in major psychiatric disorders. Biochimica et Biophysica Acta (BBA) - Biomembranes 1768:4, pages 976-993.
Crossref
Crossref
David B. Goldstein, Anna C. Need, Rinki Singh & Sanjay M. Sisodiya. (2007) Potential Genetic Causes of Heterogeneity of Treatment Effects. The American Journal of Medicine 120:4, pages S21-S25.
Crossref
Crossref
Brigitta Bondy & Ilja Spellmann. (2007) Pharmacogenetics of antipsychotics: useful for the clinician?. Current Opinion in Psychiatry 20:2, pages 126-130.
Crossref
Crossref
Andrea de Bartolomeis, Licia Vellucci, Annarita Barone, Mirko Manchia, Vincenzo De Luca, Felice Iasevoli & Christoph Correll. (2022) Clozapine's Multiple Cellular Mechanisms: What Do We Know after More than Fifty Years? a Systematic Review and Critical Assessment of Translational Mechanisms Relevant for Innovative Strategies in Treatment-Resistant Schizophrenia. SSRN Electronic Journal.
Crossref
Crossref